A case of paranoid schizophrenia complicated by scleroderma with associated esophageal dysmotility

J Psychiatr Pract. 2008 Mar;14(2):126-30. doi: 10.1097/01.pra.0000314321.32910.34.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Adult
  • Antipsychotic Agents / administration & dosage
  • Benzodiazepines / administration & dosage
  • Case Management
  • Commitment of Mentally Ill*
  • Cyclophosphamide / administration & dosage
  • Diagnosis, Differential
  • Drug Interactions
  • Enteral Nutrition / psychology
  • Esophageal Achalasia / complications*
  • Esophageal Achalasia / diagnosis
  • Esophageal Achalasia / drug therapy
  • Esophageal Achalasia / psychology
  • Female
  • Haloperidol / administration & dosage
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Olanzapine
  • Patient Acceptance of Health Care / psychology
  • Patient Care Team
  • Personality Assessment
  • Prednisone / administration & dosage
  • Referral and Consultation
  • Schizophrenia, Paranoid / complications*
  • Schizophrenia, Paranoid / diagnosis
  • Schizophrenia, Paranoid / drug therapy
  • Schizophrenia, Paranoid / psychology
  • Scleroderma, Systemic / complications*
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy
  • Scleroderma, Systemic / psychology
  • Treatment Refusal / psychology
  • Weight Loss

Substances

  • Antipsychotic Agents
  • Immunosuppressive Agents
  • Benzodiazepines
  • Cyclophosphamide
  • Haloperidol
  • Olanzapine
  • Prednisone